Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.

The US has approved lenacapavir for HIV prevention. However, experts worry that cuts to the health budget will "squander" the drug's chance of reducing infections.

A research team from Bochum and Hannover shows that the hepatitis E virus also attacks organs other than the liver.

Breakfast Club' host Charlamagne tha God talks politics, Biden's 'You ain't Black' moment, YouTubers, family, and 30 years in ...

In The Gambia, over 26,000 people live with HIV, quietly navigating a life filled with challenges most can’t see. Though the ...

HIV/AIDS remains a major public health threat worldwide, with an estimated 39.9 million people living with the disease at the ...

Discover how understanding your viral load and CD4 count puts you in control of HIV treatment and transforms confusing ...

Whether antiretroviral therapy (ART) is always completely suppressive, or HIV might continue to replicate at low levels despite ART in some people with HIV (PWH), is still debated. Here, we ...

Antiretroviral therapy (ART) initiated in the acute phase of HIV infection (AHI) results in a smaller viral reservoir. However, the impact of early HIV-specific T-cell responses on long-term reservoir ...